| Date | Form | Description | Docs | XBRL | Pages |
| 03/22/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
24 | |
| 03/11/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 02/05/21 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
3 | |
| 02/05/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 02/01/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/28/21 | 8-K | Current report filing |
|
2 | |
| 01/07/21 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
28 | |
| 01/07/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
77 |
| 12/28/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/28/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...